Company Overview

Development Stage

About the Company

[Summary] 专注癌症和代谢疾病等重大治疗领域的全球化创新药物企业

海创药业(688302.SH)是一家基于PROTAC靶向蛋白降解和氘代药物研发等技术平台,以开发具有重大临床需求的Best-in-、First-in-药物为目标的国际化创新药企业。 公司专注于癌症、代谢疾病等重大治疗领域的创新药物研发,以为患者提供有效、安全且可负担的药物为重点,致力于研发与生产具有全球权益的创新药物。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

海创药业 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

海创药业 How Fast Is Hiring Growing? (83 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 130%
  • 2024: Up 20%
  • 2023: Up 81%
  • 2022: Down 53%
海创药业 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
海创药业 Campus Recruitment & Advanced Degree Talent Demand
Master's 17 Doctorate 8
Note: How fast is hiring at 海创药业股份有限公司 growing? 海创药业2025: 154 openings (up 130%), 2024: 67 openings (up 20%), 2023: 56 openings (up 81%), 2022: 31 openings (down 53%), 2021: 66 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

海创药业 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 125%
  • 2024: Down 56%
  • 2023: Up 350%
  • 2022: Flat 0%-
海创药业 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 海创药业股份有限公司 growing? 海创药业Master's recruitment over the years: 2025: 9 openings (up 125%), 2024: 4 openings (down 56%), 2023: 9 openings (up 350%), 2022: 2 openings (flat), 2021: 2 openings.

海创药业 Doctoral Degree Job Demand Analysis

(More)
+100%
Growth Rate
2026 vs 2025
  • 2025: Up 140%
  • 2024: Flat 0%-
  • 2023: Up 150%
  • 2022: Down 33%
海创药业 Doctoral Hiring by Year: 2026 — 12 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 海创药业股份有限公司 growing? 海创药业Doctorate recruitment over the years: 2026: 24 openings (up 100%), 2025: 12 openings (up 140%), 2024: 5 openings (flat), 2023: 5 openings (up 150%), 2022: 2 openings (down 33%), 2021: 3 openings.

海创药业 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 海创药业股份有限公司? Based on an analysis of 海创药业's job postings over the past year, "医疗卫生/美容保健类" demand: 43.9%, "生物/制药/化工/环保类": 30%, "计算机/网络/技术类": 22.2%, "其他(研发和技术类)": 13.3%, "科研类": 8.9%, "机械/仪器仪表类": 2.2%. For reference only.

海创药业 — What Are the Salaries Like? (180 records)

Manage
海创药业 Salary Overview
salary range: 6K - 50K, 74.5% of roles pay ¥10-50K
Note: salary statistics are based on 180 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 海创药业股份有限公司?海创药业74.5% of positions earn 10-50K, Undergraduate salary: ¥。Chengdu salary ranking top 30,医疗卫生/美容保健类 average salary ¥23.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 海创药业

(More)
Are salaries high at 海创药业股份有限公司? We provide: 信息,临床,研究员,行政,ra,市场,运营,毒理总监,财务,msl,人力,副总,医学联络官,监察,规划,bp,hr,医学经理,实习生,推广. Click to view detailed salary analysis by job.

海创药业 — Fortune 500? (More)

海创药业 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

海创药业 Related Industry Tags

Job Category

  • 医疗卫生/美容保健类
    43.6% of total 43.6%
  • 生物/制药/化工/环保类
    29.8% of total 29.8%
  • 销售类
    27.1% of total 27.1%
  • 计算机/网络/技术类
    22.7% of total 22.7%

Education

  • 本科
    43.6% of total 43.6%
  • 大专
    22.1% of total 22.1%
  • 硕士
    18.8% of total 18.8%
  • 博士
    13.8% of total 13.8%

Experience

  • 5-10年
    38.7% of total 38.7%
  • 3-5年
    30.4% of total 30.4%
  • 1-3年
    24.3% of total 24.3%
  • 不限
    6.6% of total 6.6%
View Detailed Analysis

What does 海创药业股份有限公司 require? Who is 海创药业 hiring? 海创药业 recruitment: 医疗卫生/美容保健类占比最多占43.6%,其次是生物/制药/化工/环保类占29.8%. What education can get in at 海创药业? 本科占比最多占43.6%,其次是大专占22.1%. High education required at 海创药业? 硕士占18.8%,博士占13.8%. Work experience required at 海创药业? 5-10年占比最多占38.7%,其次是3-5年占30.4%. Where are the job locations at 海创药业? 成都占比最多占64.6%,其次是北京占13.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 9,901.5598万(元)
Legal Representative: Yuanwei Chen (陈元伟)
Date Established:
Credit Code: 915101000624182263
Registered Address: 四川省成都市高新区科园南路5号蓉药大厦1栋4层附2、3号

Partners & Suppliers

担任海创药业首次公开发行股票并在科创板上市的发行人中国法律顾问 Source
供应商 上市中介服务
为海创药业提供IPO审计及年度审计服务 Source
供应商 上市中介服务
担任海创药业首次公开发行股票并在科创板上市的保荐机构及主承销商 Source
供应商 上市中介服务
作为临床研究中心,参与海创药业多项肿瘤药物临床试验 Source
供应商 临床研究机构
作为临床试验牵头单位,为海创药业HC-1119等候选药物提供临床研究服务 Source
供应商 临床研究机构

People who follow 海创药业 also follow

海创药业 Competitors (Similar Companies)

“Professional manufacturer and operator of large-volume parenteral solu”
“Let everyone have trust and expectation in Baili because of health!”
“To become a first-class enterprise in the global diagnostics industry”
“Research, development, and production of anti-tumor and surgical medic”
连锁餐饮 比萨 饮品 餐饮
清洁能源 氢能源 生产 化工能源
电力 电力设备 电力安全工具 电力系统
“Benefit farmers, nourish consumers”
传感器 电源管理 智能电源 集成电路/IC
“Let more people enjoy the fun of traveling”
“A wholly-owned subsidiary of China Resources Double Crane, a pharmaceu”
医药供应链 药品零售 连锁 医药B2B
液压 液压设备 仪器/仪表 生产
甲醇 循环经济 煤矿开采 苯加氢
“Let everyone in the world enjoy a better life through technology”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates